Calcium Channel Blockers for the Management of Preterm Birth: A Review

Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
American Journal of Perinatology (Impact Factor: 1.91). 01/2011; 28(1):57-66. DOI: 10.1055/s-0030-1262512
Source: PubMed


Preterm birth continues to be the leading cause of perinatal morbidity and mortality. A wide range of tocolytics have been utilized for the management of preterm labor. Calcium channel blockers, namely nifedipine, gained popularity as tocolytics due to the oral route of administration, availability of immediate- and slow-release preparations, the low incidence of maternal adverse effects associated with their use, and the fact that they are inexpensive. This article reviews the available literature on the clinical utility of calcium channel blockers for acute and maintenance tocolysis with special emphasis on potential adverse effects, the most appropriate dose/regimen, and contemporary practice patterns among obstetricians. There are no randomized, placebo-controlled studies demonstrating the benefit of nifedipine in preterm labor. A suggested tocolytic protocol would be to start with the lowest dose of oral immediate-release nifedipine. For the first 48 hours thereafter, all attempts should be made not to exceed 60-mg daily doses.

Download full-text


Available from: Anwar H Nassar, Jul 07, 2014
  • Source
    • "If hypotension occurs, it is typically within the first few hours after initiation and is more likely when nifedipine is administered sublingually.19 Other adverse events, most of which occur rarely and in women with other risk factors, include pulmonary edema, dyspnea, and myocardial infarction.19 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Administration of short-term tocolytic agents can prolong pregnancy for women in preterm labor. Prolonging pregnancy has many benefits because it allows for other proven interventions, such as antenatal corticosteroid administration, to be accomplished. This review provides an overview of currently utilized tocolytic agents and the evidence demonstrating their efficacy for prolonging pregnancy by at least 48 hours. General pharmacological principles for the clinician regarding drugs in pregnancy are also briefly discussed. In general, while the choice of the best first-line short-term tocolytic drug is not clear, it is evident that use of these agents has a clear place in current obstetric therapeutics.
    International Journal of Women's Health 03/2014; 6(1):343-349. DOI:10.2147/IJWH.S44048
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the outcomes of singleton and twin pregnancies that were complicated by spontaneous preterm labor and received nifedipine tocolysis. We identified the following subjects from a computerized, hospital database: 58 singleton and 32 twin pregnancies that were between 24 and 34 weeks of gestation, admitted for spontaneous preterm labor without rupture of the membranes, and receiving tocolysis with nifedipine. Data were analyzed using the Chi-square test, the Mann-Whitney test, and the Kaplan-Meier survival analysis. Spontaneous, preterm delivery occurred in 31.1% cases of singleton and 81.3% of twin pregnancies. Although the 22% of the mothers of twins did not have cervical changes upon admission, 37% of twins were delivered within 48 h. Mean for delivery weeks from admission to 36 weeks was significantly less for twin than it was for singleton gestations (32.3 ± 1.0 vs. 35.0 ± 0.5 weeks, respectively; Mantel-Cox X (2) = 41.118; p < 0.001). The maternal side effects were not significantly different between the groups. No serious cardiovascular complication had been found in either group. Tocolysis with nifedipine is effective and safe for use in both singleton and twin gestations.
    Archives of Gynecology 11/2010; 284(4):821-6. DOI:10.1007/s00404-010-1751-3 · 1.36 Impact Factor
  • Source

    Facts, Views and Vison in ObGyn edited by Robert E. Garfield, 01/2012; Universa Press., ISBN: ISSN:202-0418
Show more